Literature DB >> 30497777

Extracellular αB-crystallin modulates the inflammatory responses.

Yong-Shun Guo1, Pei-Zhou Liang2, Shen-Zhao Lu3, Rong Chen3, Yan-Qing Yin2, Jia-Wei Zhou4.   

Abstract

Neuroinflammation is considered a challenging clinical problem. Chronic inflammatory responses play important roles in the onset and progression of various neurodegenerative diseases, including multiple sclerosis (MS). Previous studies have shown that astrocytes express small heat shock protein αB-crystallin (CRYAB) which is capable of inhibiting inflammatory responses in astrocytes per se. However, the underlying mechanisms of CRYAB-induced modulation of neuroinflammation are still not fully understood. In the present study, we investigated the role of extracellular CRYAB in the interaction between microglia and astrocytes in the context of MS-associated neuroinflammation. We found that the expression of CRYAB was profoundly increased in EAE mice. CRYAB was preferentially expressed in astrocytes and could be secreted via exosomes. Levels of exosomal CRYAB secreted from astrocytes were markedly increased under stress conditions. Furthermore, incubation of immortalized astrocytes or microglia cell lines with CRYAB remarkably suppressed astrocytes and microglia-mediated inflammatory responses in both autocrine and paracrine manners. Our results reveal a novel function for extracellular CRYAB in the regulation of neuroinflammation. Targeting extracellular CRYAB-modulated neuroinflammation is a potential therapeutic intervention for MS.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Astrocyte; EAE; Exosome; Inflammation; Microglia; αB-crystallin

Mesh:

Substances:

Year:  2018        PMID: 30497777     DOI: 10.1016/j.bbrc.2018.11.024

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  HspB5 protects mouse neural stem/progenitor cells from paraquat toxicity.

Authors:  Naveen Kumar Mekala; Shyama Sasikumar; Kranthi Kiran Akula; Yash Parekh; Ch Mohan Rao; Kiran Kumar Bokara
Journal:  Am J Stem Cells       Date:  2020-12-25

2.  A monoclonal antibody targeted to the functional peptide of αB-crystallin inhibits the chaperone and anti-apoptotic activities.

Authors:  Rooban B Nahomi; Sandip K Nandi; Ram H Nagaraj
Journal:  J Immunol Methods       Date:  2019-02-06       Impact factor: 2.303

3.  Inhibition of astrocytic DRD2 suppresses CNS inflammation in an animal model of multiple sclerosis.

Authors:  Shen-Zhao Lu; Yue Wu; Yong-Shun Guo; Pei-Zhou Liang; Shu Yin; Yan-Qing Yin; Xiu-Li Zhang; Yan-Fang Liu; Hong-Yan Wang; Yi-Chuan Xiao; Xin-Miao Liang; Jia-Wei Zhou
Journal:  J Exp Med       Date:  2022-07-25       Impact factor: 17.579

4.  Intestinal Dopamine Receptor D2 is Required for Neuroprotection Against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Dopaminergic Neurodegeneration.

Authors:  Hairong Peng; Shui Yu; Yukai Zhang; Yanqing Yin; Jiawei Zhou
Journal:  Neurosci Bull       Date:  2022-04-11       Impact factor: 5.271

5.  Novel factor in olfactory ensheathing cell-astrocyte crosstalk: Anti-inflammatory protein α-crystallin B.

Authors:  Aybike Saglam; Anne L Calof; Susan Wray
Journal:  Glia       Date:  2020-12-12       Impact factor: 8.073

Review 6.  The NFκB Antagonist CDGSH Iron-Sulfur Domain 2 Is a Promising Target for the Treatment of Neurodegenerative Diseases.

Authors:  Woon-Man Kung; Muh-Shi Lin
Journal:  Int J Mol Sci       Date:  2021-01-19       Impact factor: 5.923

Review 7.  Viral Proteins with PxxP and PY Motifs May Play a Role in Multiple Sclerosis.

Authors:  Keng-Shuo Pi; Yurou Sang; Suzana K Straus
Journal:  Viruses       Date:  2022-01-28       Impact factor: 5.048

Review 8.  Alpha B-Crystallin in Muscle Disease Prevention: The Role of Physical Activity.

Authors:  Ivan Dimauro; Daniela Caporossi
Journal:  Molecules       Date:  2022-02-08       Impact factor: 4.411

9.  Quantitative proteomic analysis after neuroprotective MyD88 inhibition in the retinal degeneration 10 mouse.

Authors:  Tal Carmy-Bennun; Ciara Myer; Sanjoy K Bhattacharya; Abigail S Hackam
Journal:  J Cell Mol Med       Date:  2021-09-25       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.